Cannabinoidergic, or cannabinergic, means "working on the endocannabinoid neurotransmitters". As with terms such as  dopaminergic and serotonergic, related proteins and cellular components involved in endocannabinoid signaling, such as the cannabinoid (CB1) receptor, as well as exogenous compounds, such as phytocannabinoids or other cannabinoids which modulate the activity of endocannabinoid system, can be described as cannabinoidergic.[1] 
 See also
  References
  
 
 |  | 
|---|
| Receptor (ligands)
 | | CB1Tooltip Cannabinoid receptor type 1 | | Agonists (abridged,
 full list)
 |  | 
|---|
 | Inverse agonists |  | 
|---|
 | Antagonists |  | 
|---|
 | 
|---|
 | CB2Tooltip Cannabinoid receptor type 2 | | Agonists |  2-AG2-AGE (noladin ether)3,3'-Diindolylmethane4-O-Methylhonokiolα-Amyrin · β-AmyrinA-796,260A-834,735A-836,339AM-1172AM-1221AM-1235AM-1241AM-2232AnandamideAZ-11713908CannabinolCaryophylleneCB-13CBS-0550CP 55,940GW-405,833 (L-768,242)GW-842,166XHU-308JTE 7-31JWH-007JWH-015JWH-018JWH-73JWH-133L-759,633L-759,656Lenabasum (anabasum)MagnololMDA-19NabitanNADAOlorinab (APD-371)PF-03550096S-444,823SER-601Serinolamide AUR-144TedalinabTHC (dronabinol)THCVTetrahydromagnololVirodhamine
 | 
|---|
 | Antagonists |  | 
|---|
 | 
|---|
 | NAGly (GPR18)
 |  | 
|---|
 | GPR55 |  | 
|---|
 | GPR119 |  | 
|---|
 | 
|---|
| Transporter (modulators)
 | | eCBTsTooltip Endocannabinoid transporter |  | 
|---|
 | 
|---|
| Enzyme (modulators)
 | | FAAHTooltip Fatty acid amide hydrolase |  | 
|---|
 | MAGL |  | 
|---|
 | ABHD6 |  Inhibitors: JZP-169JZP-430KT182KT185KT195KT203LEI-106ML294ML295ML296UCM710WWL-70
 | 
|---|
 | ABHD12 |  | 
|---|
 | 
|---|
| Others |   Others: 2-PG (directly potentiates activity of 2-AG at CB1 receptor)ARN-272 (FAAH-like anandamide transporter inhibitor)
 | 
|---|
|  See also Receptor/signaling modulators Cannabinoids (cannabinoids by structure)
 |